C. C. Cheng
C. C. Cheng publishes mostly in Organic Chemistry, Molecular Biology and Toxicology, on topics such as Synthesis and Characterization of Heterocyclic Compounds, Synthesis and Biological Evaluation and Synthesis and Reactions of Organic Compounds.
- World rank
- #4,531,468 of 7,710,434 ranked researchers
- Rank in United States
- #1,203,798 of 1,627,098
- Works
- 228
- Citations
- 3.1k
- Citations per work
- 13.4
What does C. C. Cheng research?
C. C. Cheng's work is mostly in Chemistry (48%), Biochemistry, Genetics and Molecular Biology (13%), Medicine (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences10947.8%
- Chemistry10947.8%
- Everything else6729.2%
- Life Sciences3917.0%
- Health Sciences146.0%
- Medicine146.0%
- 1Organic Chemistry46% of their works
- 2Molecular Biology13% of their works
- 3Toxicology4% of their works
- 4Oncology4% of their works
- 5Pharmacology2% of their works
- 6Spectroscopy2% of their works
Research topics
- Synthesis and Characterization of Heterocyclic Compounds
- Synthesis and Biological Evaluation
- Synthesis and Reactions of Organic Compounds
- Cancer therapeutics and mechanisms
- Synthesis and biological activity
- Bioactive Compounds and Antitumor Agents
- Quinazolinone synthesis and applications
- Chemical Synthesis and Analysis
Which keywords describe C. C. Cheng's research?
The keywords of their largest research topics: Synthesis, Biological Evaluation, Anticancer Agents, Heterocycles, Catalyst, Heterocyclic Compounds, Medicinal Chemistry and Antimicrobial Activity.
- Foldamers
- Indirubin
- Quinones
- Tubulin Inhibitors
- DNA
- Imidazoles
- Derivatives
- Scaffold
- Antimicrobial
- Antimicrobial Activity
- Heterocyclic Compounds
- Heterocycles
- Biological Evaluation
- Synthesis
- Anticancer Agents
- Catalyst
- Medicinal Chemistry
- Anticancer
- Drug Discovery
- Triazines
- Quinoxaline
- Oxazolones
- Topoisomerases
- Vascular Targeting Agents
- Toxicology
- Quinazoline
- Peptide Synthesis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 27 words, with their numbers
- Synthesis1214 topics
- Biological Evaluation893 topics
- Anticancer Agents833 topics
- Heterocycles722 topics
- Catalyst662 topics
- Heterocyclic Compounds612 topics
- Medicinal Chemistry612 topics
- Antimicrobial Activity562 topics
- Anticancer552 topics
- Antimicrobial552 topics
- Drug Discovery532 topics
- Scaffold401 topic
- Triazines401 topic
- Derivatives341 topic
- Quinoxaline341 topic
- Imidazoles321 topic
- Oxazolones321 topic
- DNA291 topic
- Topoisomerases291 topic
- Tubulin Inhibitors271 topic
- Vascular Targeting Agents271 topic
- Quinones221 topic
- Toxicology221 topic
- Indirubin151 topic
- Quinazoline151 topic
- Foldamers131 topic
- Peptide Synthesis131 topic
Where does C. C. Cheng work?
C. C. Cheng's main affiliation in the publication record is MRIGlobal, United States.
How many publications and citations does C. C. Cheng have?
OpenAlex counts 228 works and 3,051 citations for C. C. Cheng, an h-index of 29, ranking #4,531,468 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named C. C. Cheng
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about C. C. Cheng. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.